BioCentury
ARTICLE | Financial News

Taligen Therapeutics financial update

August 30, 2010 7:00 AM UTC

Taligen raised $10 million in a fourth tranche of a $65 million series B round. The series B round was secured in February 2008, and with this tranche the company has closed on $36 million. Existing i...